:

Sangeetha Gopalakrishnan1, Premkumar Jayapal2, James John3

  • 1Department of Medical Laboratory Technology, School of Allied Health Science, Sathyabama Institute of Science and Technology, Chennai, India; Division of Laboratories, Biochemistry & Hematology Section, Central Leprosy Teaching and Research Institute, Chengalpattu, India.

概括

针对肺炎球菌表面蛋白的新型疫苗提供了一种有希望的,与血清型无关的针对Streptococcus pneumoniae的战略,解决了当前疫苗的局限性,并打击了抗生素耐药性.